The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Frequently asked questions
What is the ALPS ETF Trust - ALPS Medical Breakthroughs ETF (SBIO) expense ratio?
The ALPS ETF Trust - ALPS Medical Breakthroughs ETF funds expense ratio is 0.5%.
What is ALPS ETF Trust - ALPS Medical Breakthroughs ETF (SBIO) current stock price?
As of the latest data, ALPS ETF Trust - ALPS Medical Breakthroughs ETF stock price is $53.78, with a previous close of $53.38. ALPS ETF Trust - ALPS Medical Breakthroughs ETF gained $0.40 in the last trading session, representing a 0.74% increase.
Does ALPS ETF Trust - ALPS Medical Breakthroughs ETF (SBIO) pay dividends?
No. ALPS ETF Trust - ALPS Medical Breakthroughs ETF does not pay a dividend.
